Table 1 High expression of Annexin-A2 (ANXA2) in biopsies as an indicator of the survival rate
From: Annexin A2-mediated cancer progression and therapeutic resistance in nasopharyngeal carcinoma
Tumor type | N | High ANXA2 expression (%) | p value | Results | Reference |
|---|---|---|---|---|---|
Epithelial ovarian cancer | 119 | 65/119 (54.62%) | <  0.001 | Poor survival rate | [20] |
Nasopharyngeal carcinoma | 48 | 32/48 (66.67%) | 0.025 | Poor survival rate | [8] |
Urothelial carcinoma | 232 | 123/232 (53.02%) | 0.012 | Poor survival rate | [21] |
Hepatocellular carcinoma | 84 | 62/84 (73.81%) | 0.005 | Poor survival rate | [22] |
Serous ovarian cancer | 109 | 63/109 (57.79%) | 0.044 | Poor survival rate | [23] |